Attention Deficit Hyperactivity Disorder (ADHD) is one of the most common neurodevelopmental disorders of childhood. Approximately 62% of all kids and adolescents with a diagnosis of ADHD are taking medication to treat ADHD. Patient advocates supporting kids and adolescents with ADHD should have a general understanding of common ADHD medications. Through mini-videos this class will provide foundational knowledge about ADHD medications and discuss common misconceptions and barriers associated with their use.
Learning Objectives:
Review Attention Deficit Hyperactivity Disorder (ADHD) and provide an overview of guideline-based treatment options.
Simplify pharmacotherapeutic properties of common ADHD medications used in pediatrics, including stimulants, selective norepinephrine reuptake inhibitors, and alpha-adrenergic agonists.
Break down common misconceptions associated with ADHD medications.
Examine key roles for patient advocates who are supporting kids and adolescents taking ADHD medications.
Course Details:
Title: ADHD Therapeutics Understanding Common ADHD Medications used in Pediatrics
Instructor: Stacie Lampkin, PharmD, BCPPS, BCPA, CA
After graduating from pharmacy school in 2009, Stacie pursued a pediatric pharmacy residency and a career in academia. As an associate pharmacy professor, she uses her knowledge as a board-certified pediatric pharmacy specialist and aromatherapist to educate future healthcare professionals. Stacie provides didactic teaching in the classroom and clinical pharmacy education at a pediatric outpatient center in Buffalo, NY. In 2019, she became a board-certified patient advocate after experiencing first-hand the difficulties of navigating a new health issue. Armed with education and resources; Stacie transforms overwhelm and frustration into knowledge and power. As a patient advocate, she teaches family members, patient advocates, and healthcare professionals how to be better advocates for pediatric patients.
Components: Introduction and 3 lessons on the Overview of ADHD, Medications, and Roles for Patient Advocates